We are international
Donate
TEXT SIZE   
   back

Myeloma Minute
January 9, 2014
01.13.14

January 9, 2014

Share the Minute

Facebook

Tweet!

Clinical Trials

Donate to the IMF

 



Upcoming Events




Monday, January 27, 2014
Gayla's Celebration
Traverse City, Michigan




Saturday, February 1, 2014
Myeloma Center Workshop
Denver, Colorado




February 28-March 1, 2014
Patient & Family Seminar
Boca Raton, Florida

Black Swan Research Initiative® Achievements and Look Ahead at 2014

In his blog this week, IMF Chairman Brian G.M. Durie, MD, discusses the important Black Swan Research Initiative® (BSRI®) goals achieved ahead of schedule in 2013 and looks ahead to the exciting work to come in 2014. As Dr. Durie explains, researchers have identified procedures to measure when zero Minimal Residual Disease (MRD-Zero™) has been achieved, and BSRI "is moving into high gear in the new year." READ DR. DURIE'S BLOG

x


Best of ASH 2013: What Patients Need to Know Teleconference

During this teleconference discussion and Q&A, IMF Chairman Brian G.M. Durie, MD, will highlight key information he has gleaned from over 800 myeloma abstracts presented at the 2013 annual meeting of the American Society of Hematology (ASH) that will have the biggest impact on myeloma patients, now and in the future. The ASH annual meeting is the largest global blood cancer meeting, featuring over 3,000 scientific abstracts, and was attended by more than 20,000 medical professionals. REGISTER NOW for the teleconference, being held January 16 at 7 pm ET/ 4 pm PT. View IMF ASH videos HERE. Read Support Group Leader blogs from ASH HERE

x


Cancer Treatment Parity Act Introduced in US Senate

The IMF applauds Senator Al Franken (MN) and Senator Mark Kirk (IL) for introducing the Cancer Treatment Parity Act (S. 1879), a Senate companion bill to H.R. 1801. "Passage of this legislation would mean that patients no longer have to decide between the best treatment for their cancer and their family's financial stability. Patients living with cancer across the country can focus on what really matters: surviving their cancer," said Meghan Buzby, IMF Director of US Advocacy. This bipartisan legislation would ensure patient access to anticancer treatments by requiring insurance companies to cover patient-administered and physician-administered anticancer drugs at the same cost to patients. Click here to ask your US Senator to co-sponsor S. 1879 today!

x


Vermont Support Group Leader Donates Sculpture to Cancer Center

Jan Martin Bopp, who founded the Southwestern Vermont Multiple Myeloma Support Group this year and attended his first IMF Support Group Leaders Summit, is a sculptor. His beautiful ceramic sculpture (at right), which tells the story of his journey with myeloma, will be dedicated to the Southwestern Vermont Regional Cancer Center on January 15. Read more about Jan's support group and his advocacy work HERE.

 




 

x

Join Our Mailing List
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles